StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

BioLargo's gross profit for the twelve months ending Jun 30, 2026 was $1.63M, down 74.4% year over year. For fiscal 2025 it was $3.41M, down 56.6% from the year before. Over ten years it grew 48.5% a year on average. The highest annual figure on record is $7.85M in fiscal 2024.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.41M-56.6%
FY2024Dec 31, 2024$7.85M+27.6%
FY2023Dec 31, 2023$6.15M+115.4%
FY2022Dec 31, 2022$2.86M+159.0%
FY2021Dec 31, 2021$1.10M-10.2%
FY2020Dec 31, 2020$1.23M+34.1%
FY2019Dec 31, 2019$916.00K+47.5%
FY2018Dec 31, 2018$621.00K+221.8%
FY2017Dec 31, 2017$193.00K+10.1%
FY2016Dec 31, 2016$175.23K+167.5%
FY2015Dec 31, 2015$65.52K+17.9%
FY2014Dec 31, 2014$55.55K-59.8%
FY2013Dec 31, 2013$138.29K+436.8%
FY2012Dec 31, 2012$25.76K-76.9%
FY2011Dec 31, 2011$111.43K+256.3%
FY2010Dec 31, 2010$31.28K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$675.00K-52.5%
Q1 FY2026Mar 31, 2026$458.00K-69.2%
Q4 FY2025Dec 31, 2025$128.00K-92.7%
Q3 FY2025Sep 30, 2025$372.00K-78.4%
Q2 FY2025Jun 30, 2025$1.42M-33.5%
Q1 FY2025Mar 31, 2025$1.49M-33.7%
Q4 FY2024Dec 31, 2024$1.75M-16.2%
Q3 FY2024Sep 30, 2024$1.72M+20.0%
Q2 FY2024Jun 30, 2024$2.14M+160.9%
Q1 FY2024Mar 31, 2024$2.25M+24.1%
Q4 FY2023Dec 31, 2023$2.09M+116.4%
Q3 FY2023Sep 30, 2023$1.44M+90.8%
Q2 FY2023Jun 30, 2023$819.00K+31.5%
Q1 FY2023Mar 31, 2023$1.81M+247.4%
Q4 FY2022Dec 31, 2022$965.00K+198.8%
Q3 FY2022Sep 30, 2022$752.00K+114.9%
Q2 FY2022Jun 30, 2022$623.00K+210.0%
Q1 FY2022Mar 31, 2022$521.00K+124.6%
Q4 FY2021Dec 31, 2021$323.00K-30.8%
Q3 FY2021Sep 30, 2021$350.00K-4.1%
Q2 FY2021Jun 30, 2021$201.00K-7.4%
Q1 FY2021Mar 31, 2021$232.00K+29.6%
Q4 FY2020Dec 31, 2020$467.00K+68.0%
Q3 FY2020Sep 30, 2020$365.00K+36.2%
Q2 FY2020Jun 30, 2020$217.00K+9.6%
Q1 FY2020Mar 31, 2020$179.00K+4.1%
Q4 FY2019Dec 31, 2019$278.00K+15.8%
Q3 FY2019Sep 30, 2019$268.00K+72.9%
Q2 FY2019Jun 30, 2019$198.00K+57.1%
Q1 FY2019Mar 31, 2019$172.00K+72.0%
Q4 FY2018Dec 31, 2018$240.00K+154.9%
Q3 FY2018Sep 30, 2018$155.00K+217.8%
Q2 FY2018Jun 30, 2018$126.00K+374.1%
Q1 FY2018Mar 31, 2018$100.00K+325.8%
Q4 FY2017Dec 31, 2017$94.17K+225.5%
Q3 FY2017Sep 30, 2017$48.77K-57.7%
Q2 FY2017Jun 30, 2017$26.58K–
Q1 FY2017Mar 31, 2017$23.49K–
Q4 FY2016Dec 31, 2016$28.93K–
Q3 FY2016Sep 30, 2016$115.21K–

More BioLargo figures

See a number that looks wrong?